K, S., N, M., K, T., F, S., JM, B., & D, T. (2025). Physiologically Based Pharmacokinetic Modeling of Phosphate Prodrugs─Case Studies: Fostemsavir and Fostamatinib. Molecular pharmaceutics, 22(4), 2168. https://doi.org/10.1021/acs.molpharmaceut.4c01362
Chicago Style (17th ed.) CitationK, Stamatopoulos, Mistry N, Taskar K, Salem F, Butler JM, and Tompson D. "Physiologically Based Pharmacokinetic Modeling of Phosphate Prodrugs─Case Studies: Fostemsavir and Fostamatinib." Molecular Pharmaceutics 22, no. 4 (2025): 2168. https://doi.org/10.1021/acs.molpharmaceut.4c01362.
MLA (9th ed.) CitationK, Stamatopoulos, et al. "Physiologically Based Pharmacokinetic Modeling of Phosphate Prodrugs─Case Studies: Fostemsavir and Fostamatinib." Molecular Pharmaceutics, vol. 22, no. 4, 2025, p. 2168, https://doi.org/10.1021/acs.molpharmaceut.4c01362.